PML and acute promyelocytic leukemia: It was also confirmed that treatment with As2O3 (arsenic trioxide or ATO), a drug that down-regulates PML through proteasomal-dependent degradation and that is currently used for the treatment of APL, was able to mimic the genetic loss of PML in mice (39).